View More
Review the latest evidence-based strategies on individualized early breast cancer treatment with expert commentaries, online modules, downloadable slidesets, and an Interactive Decision Support Tool that provides personalized management recommendations for treatment selection in early breast cancer.
Resources for your patients: https://www.smartpatients.com/resources/cco-ebc
In this commentary, I share my thoughts on the impact of recent data on treatment planning in early breast cancer, including how to incorporate PARP inhibition, CDK4/6 inhibition, and immunotherapy, along with the dilemmas and challenges surrounding their use.
Denise A. Yardley, MD
Read this expert commentary for an overview of our new treatment decision support tool for HER2 negative early breast cancer, which provides treatment recommendations from 5 breast cancer experts for your patients with HER2 negative early breast cancer.
Kevin Kalinsky, MD, MS
Released: September 7, 2022
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.